3 hours Teva Pharmaceutical Industries (NYSE:TEVA) Price Target Increased to $25.00 by Analysts at BarclaysMarketBeat
Barclays boosted their target price on Teva Pharmaceutical Industries from $22.00 to $25.00 and gave the stock an “overweight” rating in a report on Wednesday.
X